Literature DB >> 12542919

Moderate citrullinaemia without hyperammonaemia in a child with mutated and deficient argininosuccinate synthetase.

Wim Ruitenbeek1, Keiko Kobayashi, Mikio Iijima, Jan A M Smeitink, Udo F H Engelke, Ronney A De Abreu, Hanneke T Kwast, Takeyori Saheki, Carolien A Boelen, Jan G N De Jong, Ron A Wevers.   

Abstract

In a patient with microcephaly, feeding problems and restlessness, moderately increased serum and urine citrulline concentrations were observed. Protein and allopurinol loading did not result in additional indications for a urea cycle defect. The diagnosis of citrullinaemia was made at both the enzyme and DNA level, resulting from a novel mutation in the argininosuccinate synthetase gene. The fact that the patient has not suffered from severe deterioration, and that there were only minor abnormalities in metabolite concentrations, suggests that the argininosuccinate synthetase capacity was less affected in vivo than in vitro. In vitro nuclear magnetic resonance investigation suggested an active acetylation mechanism for citrulline. This case illustrates the importance of performing extensive biochemical and molecular investigations in order to reach a definitive diagnosis, particularly in instances of moderate citrullinaemia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542919     DOI: 10.1258/000456303321016259

Source DB:  PubMed          Journal:  Ann Clin Biochem        ISSN: 0004-5632            Impact factor:   2.057


  1 in total

1.  The role of molecular testing and enzyme analysis in the management of hypomorphic citrullinemia.

Authors:  David P Dimmock; Pamela Trapane; Annette Feigenbaum; Catherine E Keegan; Stephen Cederbaum; James Gibson; Michael J Gambello; Keith Vaux; Patricia Ward; Gregory M Rice; Jon A Wolff; William E O'Brien; Ping Fang
Journal:  Am J Med Genet A       Date:  2008-11-15       Impact factor: 2.802

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.